Skip to main content

Advertisement

Table 1 Relationship between CD44v9 expression and clinicopathological characteristics in invasive UC patients treated with CDDP-based chemotherapy against recurrence and/or metastasis after surgery

From: Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

  CD44v9  
  Negative Positive p-value
Age
  < 68 5 29 0.650
  ≥ 68 8 35
Gender
 male 9 45 0.938
 female 4 19
Tumor location
 upper tract 9 49 0.576
 bladder 4 15
Tumor grade
 G1/2 3 4 0.054
 G3 10 60
Pathological T stage
 pT2 5 7 0.013
 pT3/4 8 57
Lymphovascular invasion
 negative 5 15 0.260
 positive 8 49
Lymph node metastasis
 pNx or pN0 10 54 0.722
 pN1, 2 3 10